In recent months, experts have raised concerns about the time and costs involved in developing lifesaving vaccines. Now, Sanofi Pasteur, the Bill & Melinda Gates Foundation and the Infectious Disease Research Institute (IDRI) are joining together to do their part to improve things.
The organizations partnered to create the Global Health Vaccine Center of Innovation (GHVCI), a joint effort aimed at making a new, cheaper model for vaccines development. It'll be based in IDRI's offices in Seattle with the focus of combining each party's expertise in an effort to accelerate the development of vaccines against a range of infectious diseases, while promoting the accessibility of such vaccines.
Sanofi Pasteur will bring its experience as an international vaccine developer, manufacturer and seller, while IDRI contributes its vaccine adjuvant and formulation expertise. The Gates Foundation will commit its "knowledge, influence and financial support," a statement said.
An initial grant from the Gates Foundation will help to pay for the formation of the new entity, and, going forward, Sanofi Pasteur and Gates Foundation will fund its operation and growth, the statement said. The parties will seek additional funding based on collaborative research on individual vaccine projects. In its own statement, Sanofi Pasteur said it'll obtain access to IDRI's adjuvants and antigens through the partnership while leveraging the external R&D center.
Read the full article here